Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia

Neuroscience Research
Juan MaZhi-Bin Hao

Abstract

It has been indicated that Pyk2/Src signaling pathway is involved in modulation of N-methyl-D-aspartate-type (NMDA) glutamate receptor activity. Lithium protects against glutamate-induced excitotoxicity in cultured neurons and in animal models of diseases. The neuroprotection against excitotoxicity afforded by lithium is time-dependent, requiring treatment for 6-7 days for maximal effect. In this study, we examined the time-course and the effect of lithium on Tyr-402 phosphorylation of Pyk2 and Tyr-416 phosphorylation of Src as well as the association of Pyk2 and NMDA receptor subunit 2A (NR2A) mediated by postsynaptic density protein 95 kDa (PSD-95) in the condition of cerebral ischemia, which was induced by occlusion of the four vessels in Sprague-Dawley rats. At 6 h of reperfusion following 15 min of ischemia (I/R), the effects induced by chronic lithium were observed, including the decrease in enhanced Tyr-402 phosphorylation of Pyk2, the inhibition in increased Tyr-416 phosphorylation of Src and the attenuation in enhanced interactions of Pyk2 and PSD-95 with NR2A. Our results further suggest that the activated Pyk2 potentiates NMDA receptor function during transient brain ischemia followed by reperfusion and the above inh...Continue Reading

References

May 1, 1979·Stroke; a Journal of Cerebral Circulation·W A Pulsinelli, J B Brierley
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·E Chalecka-Franaszek, D M Chuang
Sep 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·R V BhatC M Lee

❮ Previous
Next ❯

Citations

Nov 18, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mireille BasselinStanley I Rapoport
May 1, 2012·The Journal of Biological Chemistry·Jian XuPaul J Lombroso
Sep 17, 2011·Canadian Journal of Physiology and Pharmacology·R Wix-Ramos, A Eblen-Zajjur
Sep 15, 2014·Neuroscience and Biobehavioral Reviews·Mehdi GhasemiAhmad Salehi
Dec 20, 2011·Brain Research Bulletin·Mireille BasselinStanley I Rapoport
Apr 16, 2011·Trends in Pharmacological Sciences·Mehdi Ghasemi, Ahmad Reza Dehpour
Jan 1, 2006·Drug Discovery Today. Therapeutic Strategies·Jing DuCarlos A Zarate
Nov 23, 2006·Brain Research·Robert E McCullumsmithJames H Meador-Woodruff
Apr 14, 2005·The Psychiatric Clinics of North America·Diane C Lagace, Amelia J Eisch
Dec 5, 2014·Expert Opinion on Therapeutic Targets·Christos BikisStamatios Theocharis
Dec 13, 2005·Journal of Pharmacological Sciences·Akihiko WadaHideyuki Kobayashi
Sep 9, 2017·Metallomics : Integrated Biometal Science·Magali Roux, Anthony Dosseto
Jul 7, 2021·Acta Pharmacologica Sinica·Jie ZhuNai-Hong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.